The primary objective of the South Dakota Board of Regents (SDBOR) funded 3D Center is to develop an integrated Drug, Disease and Delivery (3D) framework for drug development and build university, industry and clinical (UIC) partnerships to accelerate the translation of new treatments for cancer and other diseases.
The vision of the 3D Center is to become a nationally recognized and locally relevant center of excellence for drug development. The center’s mission is to build the infrastructure, partnerships and network for the translation and commercialization of new treatments for cancer and other diseases, vis-à-vis train the biomedical workforce and create jobs to promote economic development in the state. The center will integrate the existing multidisciplinary strengths in Drug, Disease and Delivery research at South Dakota State University, South Dakota School of Mines and Technology and other universities, clinical and industry partners to develop and commercialize technologies for human and animal diseases.
Goal 1: Development and translation of new treatments for cancer and other diseases. The 3D Center will leverage the current IP portfolio to match industry needs to expedite the preclinical and clinical development of new treatments for cancer and other diseases.
Goal 2: Development of new IP/technologies for animal and human health. The 3D Center will issue RFPs to support pipeline projects and new projects in animal and human health. The seed grant program will be used to generate preliminary data for external funding, develop partnerships and advance research commercialization.
Goal 3: Foster entrepreneurship and strengthen the biomedical/pharmaceutical workforce in the state. The 3D Center will conduct training workshops for faculty, post-docs, and graduate students in the areas of drug development, regulatory approval, intellectual property and entrepreneurship.